News

Earnings Growth & Price Strength Make CBRE Group (CBRE) a Stock to Watch

CBRE

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

2 Big Dividends on Sale as Warsh Goes "Dirty Harry" on Inflation (Yields Up to 11.9%)

BDJ, BIT

The crowd is still way too worried about interest rates--and their fear is handing us a shot at two stout monthly dividends (yielding up to 11.9%) on the cheap.

How Nasdaq Nordic Markets Led Europe’s Listing Landscape in the First Half of 2026

The first half of 2026 has solidified a defining trend in European capital markets: when global issuers, growth companies, and international debt allocators seek liquidity and resilience, Nasdaq's Nordic exchanges answer the call.

Why the stock market is taking the chip washout in stride

Chipmakers are going through a rough patch, though you wouldn't know it just by looking at the broader market.

F & GM's Deals With Micron: Is MU Stock Worth Buying Now?

MU, F, GM

Micron's Ford and GM supply deals, AI-driven HBM demand and tight memory supply strengthen its growth case after a sharp rally.

Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios

DHR, ISRG, BEAT, W, CSW

Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.

Is the Options Market Predicting a Spike in Expand Energy Stock?

EXE

Investors need to pay close attention to EXE stock based on the movements in the options market lately.

VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout

VRTX, CRNX, NBIX

Vertex to acquire CRNX for $10B, adding approved rare disease drug Palsonify and late-stage pipeline assets to expand its endocrinology portfolio.

Do Options Traders Know Something About Embraer Stock We Don't?

EMBJ

Investors need to pay close attention to EMBJ stock based on the movements in the options market lately.

Major banks give their first ratings on SpaceX and they're quite bullish: 'Apex of civilizational ambition'

BLSH

Financial underwriters of SpaceX's IPO are now free to release their equity research.